Replies to post #554 on Lineage Cell Therapeutics Inc (LCTX)

[tradetrak]

Yes, great news hey? I was really interested to see this part of the statement:

"These positive long-term findings provide additional clinical rationale that supports our focus on progressing our AST-VAC2 allogeneic (non-patient specific) dendritic cell cancer vaccine development program into a Phase 1/2a clinical trial in lung cancer..."